Singapore-based preventive health tech company Actxa has announced major upgrades to its proprietary BGEM® technology, the world’s first clinically backed, non-invasive, AI-powered blood glucose evaluation and monitoring system. The enhancements further strengthen BGEM®’s ability to deliver medical-grade glucose insights through everyday wearables, making glucose awareness more accessible and convenient.
Introducing BGEM® Glucose Range: Quick, Pain-Free Insights
A standout innovation is BGEM® Glucose Range, a medical-grade technology that estimates blood glucose levels within a numeric range using a simple one-minute measurement. Developed from extensive clinical data, this feature provides users with pain-free, meaningful insights throughout the day. By offering a cost-effective and convenient alternative to traditional glucose monitoring, BGEM® Glucose Range helps make glucose tracking more sustainable and user-friendly.
The technology allows for regular monitoring of metabolic health, enabling users to:
● Observe daily glucose patterns
● Detect post-meal glucose spikes
● Track potential Type II diabetes risks through daily observation
Designed for seamless integration with wearables, BGEM® Glucose Range combines Photoplethysmography (PPG) sensors with AI-driven analysis of digital biomarkers to estimate blood glucose levels, providing a new standard for non-invasive glucose evaluation.
Everyday Glucose Awareness with the Core Smart Ring
Actxa’s Core Smart Ring, the first in its Core range, now features the AI Glucose Scan, powered by BGEM® Glucose Status technology. This feature delivers quick insights into a user’s glucose status, offering a simple “Normal” or “Elevated” reading linked to daily habits.
Using clinically collected data, AI Glucose Scan interprets PPG signals from the ring to provide everyday glucose awareness. Combined with lifestyle and wellness guidance, the Core Smart Ring helps users make informed decisions for better metabolic health.
Shaping the Future of Preventive Health
“Glucose health is becoming a defining challenge for global preventive health, yet most monitoring solutions remain invasive, costly, or difficult to sustain,” said Marcus Soo, CEO of Actxa.
“Our mission is to make health insights simple, personal, and actionable. Actxa is empowering individuals and partners to integrate preventative health and glucose awareness into daily life.”
To learn more about Actxa, click here.
